IDEXX Laboratories, Inc.
DE ˙ XTRA ˙ US45168D1046
470,40 € ↓ -12,40 (-2,57%)
2026-06-03
AKTIENPREIS
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionAvestar Capital, LLC
Latest Disclosed Ownership736 shares
Latest Disclosed Value $ 413,551
Avestar Capital, LLC reports 0.54% decrease in ownership of IX1 / IDEXX Laboratories, Inc.

On May 13, 2026 - Avestar Capital, LLC filed a 13F-HR form disclosing ownership of 736 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $359,168 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 740 shares of IDEXX Laboratories, Inc.. This represents a change in shares of -0.54% during the quarter. The current value of the position is $346,214 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F IDEXX LABS COM 45168D104 736 -4 -0.54 414 -17.40 0.0266
2026-02-10 2025-12-31 13F IDEXX LABS COM 45168D104 740 -179 -19.48 501 -14.82 0.0324
2025-11-07 2025-09-30 13F IDEXX LABS COM 45168D104 919 280 43.82 587 71.64 0.0384
2025-08-13 2025-06-30 13F IDEXX LABS COM 45168D104 639 -59 -8.45 343 16.72 0.0234
2025-05-14 2025-03-31 13F IDEXX LABS COM 45168D104 698 -106 -13.18 293 -11.75 0.0254
2025-01-29 2024-12-31 13F IDEXX LABS COM 45168D104 804 45 5.93 332 -13.32 0.0283
2024-11-13 2024-09-30 13F IDEXX LABS COM 45168D104 759 60 8.58 383 12.65 0.0395
2024-08-08 2024-06-30 13F IDEXX LABS COM 45168D104 699 137 24.38 341 12.21 0.0350
2024-05-10 2024-03-31 13F IDEXX LABS COM 45168D104 562 111 24.61 303 21.20 0.0318
2024-02-12 2023-12-31 13F IDEXX LABS COM 45168D104 451 451 250 0.0284
2019-11-15 2019-09-30 13F/A-1 IDEXX LABORATORIES INC COM USD0.10 COM 45168D104 0 -18 -100.00 0 -100.00
2019-08-06 2019-06-30 13F IDEXX LABORATORIES INC COM USD0.10 COM 45168D104 18 0 0.00 3 50.00 0.0019
2019-05-09 2019-03-31 13F IDEXX LABORATORIES INC COM USD0.10 COM 45168D104 18 0 0.00 2 0.00 0.0013
2019-01-25 2018-12-31 13F IDEXX LABS COM 45168D104 18 10 125.00 2 100.00 0.0014
2018-10-23 2018-09-30 13F IDEXX LABS COM 45168D104 8 0 0.00 1 0.00 0.0006
2018-08-10 2018-06-30 13F IDEXX LABS COM 45168D104 8 0 0.00 1 0.00 0.0006
2018-05-10 2018-03-31 13F IDEXX LABS COM 45168D104 8 8 1 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.